Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Clin Cancer Res. 2012 Jun 14;18(16):4225–4233. doi: 10.1158/1078-0432.CCR-12-0686

Table 1.

O’Brien-Fleming Stopping Boundaries (for p-values) and Maximum Sample Sizes for 1-β = 0.80, RRR=2.0, interim analysis after f=0.50 accrual, and each of pre-specified Type I error rates, α = 0.10 and 0.20.

OF Stopping Boundaries
α Early efficacy
(c1)
Early futility
(c2)
Overall efficacy
(d)
Max N
0.10 0.0200 0.4566 0.0940 101
0.20 0.0699 0.5765 0.1803 65